{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:19:55Z","timestamp":1788776395314,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671005"],"award-info":[{"award-number":["81671005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-017-1507-6","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T07:22:13Z","timestamp":1517296933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents"],"prefix":"10.1186","volume":"20","author":[{"given":"Xia","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. New Engl J Med. 2012;366:539\u201351.","journal-title":"New Engl J Med"},{"key":"1507_CR2","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","volume":"13","author":"P Brito-Zeron","year":"2014","unstructured":"Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13:1203\u201310.","journal-title":"Autoimmun Rev"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/lary.25387","volume":"125","author":"X Hong","year":"2015","unstructured":"Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ, et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015;125:2113\u20138.","journal-title":"Laryngoscope"},{"key":"1507_CR4","first-page":"85","volume":"18","author":"X Hong","year":"2015","unstructured":"Hong X, Li W, Su JZ, Wang Z, Yu GY. Internal organ involvement in IgG4-related sialadenitis: a systemic review. Chin J Dent Res. 2015;18:85\u201394.","journal-title":"Chin J Dent Res"},{"key":"1507_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.6.","journal-title":"Mod Rheumatol"},{"key":"1507_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/14397595.2014.950036","volume":"25","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and\/or sialadenitis: results from the SMART database. Mod Rheumatol. 2015;25:199\u2013204.","journal-title":"Mod Rheumatol"},{"key":"1507_CR7","doi-asserted-by":"publisher","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","volume":"95","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine. 2016;95:e4002.","journal-title":"Medicine"},{"key":"1507_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.archoralbio.2016.05.012","volume":"69","author":"Z Wang","year":"2016","unstructured":"Wang Z, Li W, Hong X, Su JZ, Hua H, Peng X, et al. Minor salivary glands function is decreased in hyposalivation-related diseases. Arch Oral Biol. 2016;69:63\u201370.","journal-title":"Arch Oral Biol"},{"key":"1507_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1507_CR10","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11136-013-0420-y","volume":"22","author":"SL He","year":"2013","unstructured":"He SL, Wang JH, Li M. Validation of the Chinese version of the summated xerostomia inventory (SXI). Qual Life Res. 2013;22:2843\u20137.","journal-title":"Qual Life Res"},{"key":"1507_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13075-015-0698-y","volume":"17","author":"W Li","year":"2015","unstructured":"Li W, Chen Y, Sun ZP, Cai ZG, Li TT, Zhang L, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis. Arthritis Res Ther. 2015;17:186.","journal-title":"Arthritis Res Ther"},{"key":"1507_CR12","first-page":"257","volume":"41","author":"W Aung","year":"2000","unstructured":"Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H. Sj\u00f6gren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med. 2000;41:257\u201362.","journal-title":"J Nucl Med"},{"key":"1507_CR13","first-page":"288","volume":"46","author":"W Li","year":"2014","unstructured":"Li W, Sun Z, Liu XJ, Yu G. Volume measurements of human parotid and submandibular glands [Article in Chinese]. J Peking University (Health Sciences). 2014;46:288\u201393.","journal-title":"J Peking University (Health Sciences)"},{"key":"1507_CR14","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00784-012-0905-z","volume":"17","author":"M Moriyama","year":"2013","unstructured":"Moriyama M, Tanaka A, Maehara T, Ohyama Y, Shimizu M, Nakashima H, et al. Clinical characteristics of Mikulicz's disease as an IgG4-related disease. Clin Oral Investig. 2013;17:1995\u20132002.","journal-title":"Clin Oral Investig"},{"key":"1507_CR15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688\u201399.","journal-title":"Arthritis Rheumatol"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10157-008-0127-5","volume":"13","author":"A Aoki","year":"2009","unstructured":"Aoki A, Sato K, Itabashi M, Takei T, Yoshida T, Arai J, et al. A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4. Clin Exp Nephrol. 2009;13:367\u201372.","journal-title":"Clin Exp Nephrol"},{"key":"1507_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5812\/nephropathol.10549","volume":"2","author":"D Rolla","year":"2013","unstructured":"Rolla D, Bellino D, Peloso G, Pia Rastaldi M, Simonini P, Louis RJ. The first case of IgG4-related disease in Italy. J Nephropathol. 2013;2:144\u20139.","journal-title":"J Nephropathol"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/RHU.0b013e3181b5d631","volume":"15","author":"S Dhobale","year":"2009","unstructured":"Dhobale S, Bedetti C, Killian P, Ilyas M, Liput J, Jasnosz K, et al. IgG4 related sclerosing disease with multiple organ involvements and response to corticosteroid treatment. J Clin Rheumatol. 2009;15:354\u20137.","journal-title":"J Clin Rheumatol"},{"key":"1507_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","volume":"51","author":"G Ruiz-Irastorza","year":"2012","unstructured":"Ruiz-Irastorza G, Danza A, Khamashta M. Glucocorticoid use and abuse in SLE. Rheumatology. 2012;51:1145\u201353.","journal-title":"Rheumatology"},{"key":"1507_CR20","doi-asserted-by":"crossref","unstructured":"Zhu W, Ye L, Shen L, Jiao Q, Huang F, Han R, et al. A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 2014;99:1999\u20132007.","DOI":"10.1210\/jc.2013-3919"},{"key":"1507_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u201315.","journal-title":"Gut"},{"key":"1507_CR22","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"Y Fei","year":"2017","unstructured":"Fei Y, Chen Y, Zhang P, Chen H, Wu D, Zhao L, et al. Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017;7:6195.","journal-title":"Sci Rep"},{"key":"1507_CR23","doi-asserted-by":"publisher","unstructured":"Gupta N, Mathew J, Mohan H, Chowdhury SD, Kurien RT, Christopher DJ, et al. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India. Rheumatol Int. 2017. https:\/\/doi.org\/10.1007\/s00296-017-3730-5 .","DOI":"10.1007\/s00296-017-3730-5"},{"key":"1507_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/096120330000900106","volume":"9","author":"H Amano","year":"2000","unstructured":"Amano H, Morimoto S, Kaneko H, Tokano Y, Takasaki Y, Hashimoto H. Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers. Lupus. 2000;9:26\u201332.","journal-title":"Lupus"},{"key":"1507_CR25","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755\u201362.","journal-title":"Arthritis Rheum"},{"key":"1507_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91:57\u201366.","journal-title":"Medicine"},{"key":"1507_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00393-016-0142-y","volume":"75","author":"CA Perugino","year":"2016","unstructured":"Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75:681\u20136.","journal-title":"Z Rheumatol"},{"key":"1507_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology"},{"key":"1507_CR29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771\u20136.","journal-title":"Gut"},{"key":"1507_CR30","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol"},{"key":"1507_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajo.2012.07.024","volume":"155","author":"T Kubota","year":"2013","unstructured":"Kubota T, Katayama M, Moritani S, Yoshino T. Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment. Am J Ophthalmol. 2013;155:373\u20139. e1.","journal-title":"Am J Ophthalmol"},{"key":"1507_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5415\/apallergy.2014.4.3.172","volume":"4","author":"J Yun","year":"2014","unstructured":"Yun J, Wienholt L, Adelstein S. Poor positive predictive value of serum immunoglobulin G4 concentrations in the diagnosis of immunoglobulin G4-related sclerosing disease. Asia Pac Allergy. 2014;4:172\u20136.","journal-title":"Asia Pac Allergy"},{"key":"1507_CR33","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology. 2015;54:1982\u201390.","journal-title":"Rheumatology"},{"key":"1507_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology. 2016;55:1000\u20138.","journal-title":"Rheumatology"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1507-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:45:52Z","timestamp":1570650352000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1507-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1507-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee for Human Experiments of Peking University School of Stomatology. Informed consent was obtained from all the patients included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}